Posted on: 21 Sep 22
Dr Muhunthan Thillai CEO said "We are really excited that Dr Fernandez has joined us to assist the company with our data strategy as we expand operations. Xose brings over 25 years’ experience...
Dr Muhunthan Thillai CEO said "We are really excited that Dr Fernandez has joined us to assist the company with our data strategy as we expand operations. Xose brings over 25 years’ experience in digital and innovation solutions. During his career, he has held senior roles at a variety of organisations, most recently as the founding Chief Data Officer at Institut Curie in Paris. He has worked on a large number of significant projects across Europe aimed at improving the use of data in cancer. He has recently stepped down from Curie and returned to the UK to continue his work in data strategy implementation. His wealth of knowledge and expertise will complement the strengths of our Leadership Team and will be invaluable to us as we deliver on our mission to solve complex diseases through data curation."
Dr Fernandez said: "I am delighted to share my expertise at this vital inflection point as Qureight approaches a new round of expansion and begins to leverage new data sets to fuel their growing solution portfolio. This next phase of growth at the company will be transformative for millions of patients with complex diseases as new drugs enter clinical trials for difficult to manage conditions such as IPF and pulmonary hypertension."